Study of ozanimod use during pregnancy in people with MS
Part of Brain & nervous system, Immune system & allergy clinical trials.
This trial looks at the safety of ozanimod taken during pregnancy for parents with multiple sclerosis and for their babies after birth. It may help doctors understand the risks and benefits of this medicine during early pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of multiple sclerosis (MS).
- You are currently pregnant or recently became pregnant.
- You live in the United States, Canada, or Germany.
- You have not taken other certain MS medicines in the first trimester (early pregnancy).
- Specifically, you were not exposed to other S1P therapies, cladribine, or mitoxantrone during the first trimester.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows pregnant people with multiple sclerosis (MS) who took Mayzent (siponimod) to understand safety for pregnancy outcomes. It compares them with other groups to see whether there are any differences in birth results.
This study looks at how certain multiple sclerosis medications (monoclonal antibodies) might affect the immune system of children whose mothers took them during pregnancy. It aims to understand if these treatments have any impact on the baby's developing immune system.
This study looks at the safety of Kesimpta (a multiple sclerosis medication) during pregnancy. It compares outcomes for women who took Kesimpta or other MS drugs while pregnant to those who did not.
This study tracks pregnant women with certain chronic health conditions (like multiple sclerosis, lupus, or rheumatoid arthritis) and healthy pregnant women as a comparison group. It aims to understand how these conditions and their treatments affect pregnancy, the baby, and breast milk.
This registry collects information about pregnancy outcomes in people with multiple sclerosis (MS) who have taken Kesimpta (ofatumumab) during pregnancy or shortly before it. It may help doctors better understand safety and developmental outcomes for babies.
This study looks at people with multiple sclerosis who have taken Zeposia (ozanimod) and later developed a rare brain infection called PML. The goal is to understand how often this happens and to confirm cases.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.